Maintenance fees coming due
239 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Nov 16, 2026. Unpaid by May 17, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,648,253 | Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof In force Fee due Nov 16, 2026 Lapses if unpaid May 17, 2027 · Medium confidence | Novartis AG | In force | Nov 16, 2026 | May 17, 2027 | Medium confidence | |
| US 11,654,144 | Crystalline Forms of 5-Bromo-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-Amine and New Salts In force Fee due Nov 23, 2026 Lapses if unpaid May 24, 2027 · High confidence | Novartis AG | In force | Nov 23, 2026 | May 24, 2027 | High confidence | |
| US 9,045,470 | Compounds and Compositions as TLR Activity Modulators In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | Novartis AG | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 9,045,546 | Molecules And Methods For Modulating TMEM16A Activities In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | Novartis AG | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 10,308,628 | Heterocyclic Compounds and Methods for Their Use In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | Novartis AG | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 10,308,660 | Compounds and Compositions for Inhibiting the Activity of SHP2 In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | Novartis AG | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 10,308,717 | TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | Novartis AG | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 11,667,613 | Antiviral Pyrazolopyridinone Compounds In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 · High confidence | Novartis AG | In force | Dec 6, 2026 | Jun 7, 2027 | High confidence | |
| US 11,667,691 | Treatment of Cancer Using Chimeric CD3 Receptor Proteins In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 · High confidence | Novartis AG and The Trustees of the University of Pennsylvania | In force | Dec 6, 2026 | Jun 7, 2027 | High confidence | |
| US 9,050,267 | Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · High confidence | Novartis AG | In force | Dec 9, 2026 | Jun 9, 2027 | High confidence | |
| 229 more maintenance fees coming due in the 12 months from Nov 16, 2026 · Pro | |||||||
10 of 239 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.